Cutting-edge industrial plant

our Manufacturing site

State-of-the-art facility

from lab to industrial scale

Thanks to our teams and state-of-the-art equipment, our company can produce a wide range of probiotics and postbiotics tailored to specific requirements and deliver high-quality services to our clients.

R&D laboratorySpecialist team in microbiology, focusing on the optimization of your probiotics/ postbiotics and next-generation strains. Expertise in molecular biology and capabilities in genome and genetic characterization.

A factory Equipped with large-scale fermenters and high-performance freeze-drying devices, with the ability to apply designed and optimized efficient production processes and stabilize bioproducts.

Bioprox Healthcare’s pilot facility is crucial for the successful transition of new production processes and technologies from laboratory to commercial scale. Both our R&D and production teams collaborate for a seamless transition.

End-to-end development

for bacterial production

Bioprox’s services encompass the entire production process, ensuring high-quality outcomes at every stage:

Fermentation using high-capacity and cutting-edge fermenters to cultivate microorganisms under optimal conditions

Separation of biomass by centrifugation or ultrafiltration

High-performance drying step

Grinding under controlled atmosphere with relative humidity and at different granulometries

Blending

single or multi-strains blends with excipients

Interested by CDMO services ?

highly skilled team

Processes managed by highly skilled engineers and technicians

"Together with my engineer and technician colleagues, we leverage our scientific and technical expertise to develop innovative solutions. With decades of experience in scaling up and industrial operations, we transform laboratory processes into sustainable processes at a commercial scale”.

Quentin, industrial fermentation technician – Bioprox

discover our team

Thriving development

Advancing our production capabilities since 1975

As part of Bioprox's growth strategy, a major expansion of its industrial site is currently completed, doubling its production capacity. This expansion will significantly strengthen the company's ability to supply both national and international markets. This is the third major expansion the plant has undergone since its foundation in 1975.

OUR history

Explore our milestones

1975

1985

1998

2003

2009

2011

2016

2019

2023

1975
Acquisition of the Noyant dairy factory
and its conversion into an industrial site. Transfer of activities from the previous factory in Fourcarmont (Normandy).

1985
Construction of the fermentation and freeze-drying workshop
producing lactic acid bacteria, ripening cultures, and oenological yeasts.

1998
Extension of commercial team

2003
Second significant increasein production capacities to meet growing demands.

2009
Relocation of the R&D centre
from Château-Renault to the Noyant site for seamless lab-to-industrial scale transfer.

2011
New business unit dedicated to probiotics

2016
Creation of an industrial workshop within the factory
for the new activity of soil microorganism biosolutions with Cybèle Agrocare.

2019
Expansion of the R&D center
Increasing lab space to 1000 m².

2023
Third modernisation and investment in new bioprocess technologies
This strategic expansion not only doubles our industrial fermentation capacity but also deeply transforms our production processes by integrating the latest technologies.

"The manufacturing site in Noyant is currently undergoing significant expansion.""This initiative is pivotal as we aim to support the average annual growth of 30% witnessed over the past decade. Indeed, the modernisation not only enhances our operational robustness but also underscores our commitment to meeting the growing demand and requirements to a “T”. Bioprox Healthcare has always been able to rely on knowledge of industrial processes and the properties of cultivated microorganisms. We do have this level of technicity thanks to our sister company, Bioprox Cultures, a French specialist in large-scale industrial fermentation since 1975. The company has developed a solid industrial production activity for over 50 bacterial species as well as high-quality consulting services. This expertise is fundamental to enhancing the effectiveness of probiotics in our clients' future products, solidifying Bioprox's position in the competitive landscape of probiotics’ sector."

Eric De Mol, Bioprox Healthcare’s General Manager — January 2024

Our certifications

Ensuring the best quality to our customers

We ensure high-quality processes and efficient facility operations. We strictly adhere to current regulatory standards and foster a culture of quality compliance.

Certified ISO 9001 manufacturing site
Certified FSSC 22000 manufacturing site
Halal production
Kosher production
l Non-GMO - Allergen free

Our R&D centreOur CDMO services

Interested by our services ?

contact us
Update cookies preferences